Gelarium® Hypericum (Helarium® Hypericum)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

Ha 1 pills:

Active components:


Deerslayer perforated grass extract dry

- 285.00 mg

(4.5-6.7: 1, extractant ethanol 60%)


Excipients:


Silica colloidal dioxide

- 15.00 mg

Potato starch

- 40.00 mg

Lactose

- 56.00 mg

Magnesium stearate

- 4.00 mg

Sheath dragee:


Shellac

- 6.483 mg

Talc

- 69.941 mg

Calcium carbonate

- 23,136 mg

Titanium dioxide (E 171)

- 9.417 mg

Sucrose

- 28.444 mg

Kaolin

- 3.020 mg

Arabian gum

- 9.076 mg

Macrogol

- 0.432 mg

Quinoline yellow (E 104)

- 0.015 mg

Green lacquer (E 104 / E132)

0.036 mg

Description:

Round, biconvex dragees, covered with a shell of greenish-yellow color.

Pharmacotherapeutic group:An antidepressant of vegetable origin
ATX: & nbsp
  • Other antidepressants
    • Pharmacodynamics:

    Means of plant origin. Has antidepressant and anxiolytic (reduces anxiety, stress, improves mood) action.

    Indications:

    Psycho-vegetative disorders (depression of mood, apathy), neurotic reactions.

    Depressive states of mild and moderate severity.

    Contraindications:

    Individual hypersensitivity to the components of the drug, children under 12 years of age (due to inadequate clinical data).

    Insufficiency of lactase, lactose intolerance, glucose-galactose malabsorption, sugar / isomaltase deficiency,intolerance to fructose.

    The presence of photosensitization (increased sensitivity) of the skin to ultraviolet radiation.

    Simultaneous use with cyclosporine, tacrolimus (for systemic use), amprenavir, indinavir and other protease inhibitors (in the treatment of HIV-positive patients), as well as with irinotecan and warfarin; with monoamine oxidase inhibitors (the interval between admission should be at least 14 days).

    Pregnancy and lactation:

    The drug should not be taken during pregnancy and during breastfeeding, tk. There is insufficient experience in the use of the drug during these periods.

    Dosing and Administration:

    Inside, adults and children over 12 years of age take 1 pills 3 times a day with meals. Dragee should be swallowed without chewing, if necessary, washed down with water.

    The drug should be taken at least 4 weeks.

    If symptoms persist for more than 4 weeks, you should consult your doctor.

    Side effects:

    Possible allergic reactions: skin itching, rash, eczema, skin pigmentation, photosensitization (more often in HIV-infected patients), increased sensitization to animal wool.

    From the central nervous system: anxiety, excessive fatigue, headache.

    From the digestive system: nausea, abdominal pain (including in the epigastric region), dryness of the oral mucosa, flatulence, diarrhea or constipation, anorexia.

    From the hematopoiesis: Iron-deficiency anemia.

    Overdose:

    In case of an overdose, dose-dependent side effects may be increased.

    Treatment: symptomatic; In addition, patients should avoid sunlight or ultraviolet radiation for 1-2 weeks.

    Interaction:

    Reduces the effectiveness of indirect anticoagulants (fenprokumona, warfarin), imatinib and other cytostatics, midazolam, digoxin, amitriptyline, fexofenadine, benzodiazepines, nortriptyline, theophylline, methadone, verapamil, simvastatin, finasteride.

    When taken concomitantly with certain antidepressants, such as nefazodone, paroxetine, sertraline, buspirone, tryptans may enhance their action (with such symptoms as nausea, vomiting, fear, anxiety, confusion).

    The drug is able to enhance the photosensitizing effect of several other drugs: tetracyclines, sulfonamides, thiazide diuretics, quinolones, piroxicam.

    Lengthens sleep caused by drugs for general anesthesia and narcotic analgesics, but shortens sleep caused by barbiturates.

    Reduces the hypotensive effect of reserpine.

    Reduces the concentration of cyclosporine in the blood.

    St. John's wort cuts down the concentration in the blood and the effectiveness of indinavir therapy.

    With simultaneous use with ethinyl estradiol and desogestrel, the risk of bleeding "breakthrough" increases.

    Increases the metabolic rate of theophylline.

    Reducing the concentration in the blood of digoxin, reduces its effectiveness.

    For women taking oral contraceptives, additional contraceptive methods should be used during treatment with the drug.

    Special instructions:

    The drug may be prescribed to patients with diabetes, since one dragee contains less than 0.03 of the counted "bread units" (XE).

    During the treatment it is necessary to refrain from using ethanol-containing beverages and for 1-2 weeks to avoid ultraviolet radiation (including solarium, UV lamps, prolonged exposure to sunlight).

    Effect on the ability to drive transp. cf. and fur:

    The drug has no effect on the ability to perform potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions (including driving, working with moving mechanisms).

    Form release / dosage:Dragee.
    Packaging:

    For 15, 20 or 25 dragees in a blister of aluminum foil (bottom) and polyvinyl chloride / polyvinylidene chloride film (top).

    2 blisters (15 tablets each), 3 (20 tablets each) or 4 (25 tablets) blisters together with instructions for use are placed in a folding cardboard box.

    Storage conditions:

    In a dry, the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children in the place.

    Shelf life:
    3 years.

    Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N014575
    Date of registration:11.10.2011 / 30.05.2013
    Expiration Date:Unlimited
    The owner of the registration certificate:Bionoric CEBionoric CE Germany
    Manufacturer: & nbsp
    Representation: & nbspBIONORIKA LLC BIONORIKA LLC Russia
    Information update date: & nbsp20.03.2017
    Illustrated instructions
      Instructions
      Up